Ghosts of Exubera Haunt Afrezza As Lung Function, Cancer Concerns Weigh Heavily
Executive Summary
FDA advisory committee review of MannKind’s inhaled insulin revisits safety issues that troubled Pfizer’s first-of-its-kind product, including a potential lung cancer risk and declines in pulmonary function.